Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 439014, 6 pages
http://dx.doi.org/10.1155/2015/439014
Clinical Study

Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer

1Department of Pain, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210008, China
2State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu 210093, China

Received 19 May 2015; Accepted 7 September 2015

Academic Editor: Zhong Xie

Copyright © 2015 Ying Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. J. Clement, B. Beuselinck, P. G. Mertens, P. Cornelissen, and J. Menten, “Pain management in palliative cancer patients: a prospective observational study on the use of high dosages of transdermal buprenorphine,” Acta Clinica Belgica, vol. 68, no. 2, pp. 87–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. H. S. Gilmer-Hill, J. E. Boggan, K. A. Smith, and F. C. Wagner Jr., “Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature,” Surgical Neurology, vol. 51, no. 1, pp. 12–15, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. T. R. Deer, H. S. Smith, A. Burton et al., “Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain,” Pain Physician, vol. 14, no. 3, pp. 283–312, 2011. View at Google Scholar · View at Scopus
  4. T. Deer, E. S. Krames, S. J. Hassenbusch et al., “Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel,” Neuromodulation: Technology at the Neural Interface, vol. 10, no. 4, pp. 300–328, 2007. View at Publisher · View at Google Scholar
  5. J. A. Paice, “Intrathecal morphine infusion for intractable cancer pain: a new use for implanted pumps,” Oncology Nursing Forum, vol. 13, no. 3, pp. 41–47, 1986. View at Google Scholar · View at Scopus
  6. O. A. de Leon-Casasola, “Current developments in opioid therapy for management of cancer pain,” Clinical Journal of Pain, vol. 24, supplement 10, pp. S3–S7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Yamamoto, “Mechanisms of the development of neuropathic pain and its treatment,” Nihon Hansenbyo Gakkai Zasshi, vol. 77, no. 3, pp. 215–218, 2008. View at Google Scholar
  8. E. S. Krames, “Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines,” Journal of Pain and Symptom Management, vol. 11, no. 6, pp. 333–352, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Paice, R. D. Penn, and S. Shott, “Intraspinal morphine for chronic pain: a retrospective, multicenter study,” Journal of Pain and Symptom Management, vol. 11, no. 2, pp. 71–80, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. T. J. Grudt and J. T. Williams, “κ-opioid receptors also increase potassium conductance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11429–11432, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. T. L. Yaksh, “Pharmacology and mechanisms of opioid analgesic activity,” Acta Anaesthesiologica Scandinavica, vol. 41, no. 1, pp. 94–111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. E. T. Piros, P. L. Prather, H. H. Loh, P. Y. Law, C. J. Evans, and T. G. Hales, “Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells,” Molecular Pharmacology, vol. 47, no. 5, pp. 1041–1049, 1995. View at Google Scholar · View at Scopus
  13. S. A. Schug, D. Saunders, I. Kurowski, and M. J. Paech, “Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia,” CNS Drugs, vol. 20, no. 11, pp. 917–933, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. R. Chaplan, F. W. Bach, S. L. Shafer, and T. L. Yaksh, “Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats,” Anesthesiology, vol. 83, no. 4, pp. 775–785, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Bennett, K. Burchiel, E. Buchser et al., “Clinical guidelines for intraspinal infusion: report of an expert panel,” Journal of Pain and Symptom Management, vol. 20, no. 2, pp. S37–S43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. H. Hong, S. Y. Roh, S. Y. Kim et al., “Change in cancer pain management in Korea between 2001 and 2006: results of two nationwide surveys,” Journal of Pain and Symptom Management, vol. 41, no. 1, pp. 93–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. V. T. Malhotra, J. Root, J. Kesselbrenner et al., “Intrathecal pain pump infusions for intractable cancer pain: an algorithm for dosing without a neuraxial trial,” Anesthesia and Analgesia, vol. 116, no. 6, pp. 1364–1370, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tung, K. Maliniak, R. Tenicela, and P. Winter, “Intrathecal morphine for intraoperative and postoperative analgesia,” Journal of the American Medical Association, vol. 244, no. 23, pp. 2637–2638, 1980. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Kshatri, S. J. McGarrity, and M. B. Hahn, “Patient-controlled analgesia using ropivacaine via an intrathecal catheter,” Regional Anesthesia and Pain Medicine, vol. 23, no. 3, pp. 320–322, 1998. View at Google Scholar · View at Scopus
  20. S.-Y. Nah, D. Saya, J. Barg, and Z. Vogel, “Opiate receptor agonists regulate phosphorylation of synapsin I in cocultures of rat spinal cord and dorsal root ganglion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 9, pp. 4052–4056, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. G. J. Grant, M. Cascio, M. I. Zakowski, L. Langerman, and H. Turndorf, “Intrathecal administration of liposomal morphine in a mouse model,” Anesthesia & Analgesia, vol. 81, no. 3, pp. 514–518, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Kroin, A. Ali, M. York, and R. D. Penn, “The distribution of medication along the spinal canal after chronic intrathecal administration,” Neurosurgery, vol. 33, no. 2, pp. 226–230, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. G. R. Lauretti, M. P. Reis, W. A. Prado, and J. G. Klamt, “Dose-response study of intrathecal morphine versus intrathecal neostigmine, their combination, or placebo for postoperative analgesia in patients undergoing anterior and posterior vaginoplasty,” Anesthesia and Analgesia, vol. 82, no. 6, pp. 1182–1187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-C. Hung, C.-Y. Chen, P. Lirk et al., “Magnesium sulfate diminishes the effects of amide local anesthetics in rat sciatic-nerve block,” Regional Anesthesia and Pain Medicine, vol. 32, no. 4, pp. 288–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. K. A. Follett, P. W. Hitchon, J. Piper, V. Kumar, G. Clamon, and M. P. Jones, “Response of intractable pain to continuous intrathecal morphine: a retrospective study,” Pain, vol. 49, no. 1, pp. 21–25, 1992. View at Publisher · View at Google Scholar · View at Scopus